Pneumonia in the face of COVID-19
- PMID: 32996786
- PMCID: PMC7839244
- DOI: 10.1152/ajplung.00447.2020
Pneumonia in the face of COVID-19
Keywords: ARDS; COVID-19; antimicrobial drug resistance; barrier failure; pneumonia.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Comment on
-
World Pneumonia Day during a global pneumonia pandemic: 12 November 2020.Am J Physiol Lung Cell Mol Physiol. 2020 Nov 1;319(5):L859-L860. doi: 10.1152/ajplung.00462.2020. Epub 2020 Sep 30. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32997505 Free PMC article. No abstract available.
-
Saving young children from forgotten killer: pneumonia.Am J Physiol Lung Cell Mol Physiol. 2020 Nov 1;319(5):L861-L862. doi: 10.1152/ajplung.00471.2020. Epub 2020 Oct 14. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 33050729 No abstract available.
References
-
- Balakrishna S, Song W, Achanta S, Doran SF, Liu B, Kaelberer MM, Yu Z, Sui A, Cheung M, Leishman E, Eidam HS, Ye G, Willette RN, Thorneloe KS, Bradshaw HB, Matalon S, Jordt SE. TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 307: L158–L172, 2014. doi:10.1152/ajplung.00065.2014. - DOI - PMC - PubMed
-
- Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315: 788–800, 2016. doi:10.1001/jama.2016.0291. - DOI - PubMed
-
- Bonniaud P, Fabre A, Frossard N, Guignabert C, Inman M, Kuebler WM, Maes T, Shi W, Stampfli M, Uhlig S, White E, Witzenrath M, Bellaye PS, Crestani B, Eickelberg O, Fehrenbach H, Guenther A, Jenkins G, Joos G, Magnan A, Maitre B, Maus UA, Reinhold P, Vernooy JHJ, Richeldi L, Kolb M. Optimising experimental research in respiratory diseases: an ERS statement. Eur Respir J 51: 1702133, 2018. doi:10.1183/13993003.02133-2017. - DOI - PubMed
-
- Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, Najafian B, Deutsch G, Lacy JM, Williams T, Yarid N, Marshall DA. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet 396: 320–332, 2020. doi:10.1016/S0140-6736(20)31305-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources